CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues
Total revenues	$ 12,400,325	$ 10,596,428	$ 33,584,666	$ 27,415,843
Cost of revenues	6,068,207	4,847,780	16,589,139	11,971,135
Gross profit	6,332,118	5,748,648	16,995,527	15,444,708
Operating expenses
Selling, general and administrative	4,696,509	4,386,757	14,946,584	13,283,645
Depreciation and amortization	1,045,177	738,883	2,848,194	2,131,234
Total operating expenses	5,741,686	5,125,640	17,794,778	15,414,879
Income (loss) from operations	590,432	623,008	(799,251)	29,829
Other income
Interest income, net	615,324	265,284	1,800,388	349,847
Income before income tax provision	1,205,756	888,292	1,001,137	379,676
Income tax provision	105,152	36,183	164,819	64,996
Net income	$ 1,100,604	$ 852,109	$ 836,318	$ 314,680
Net income per share
Basic	$ 0.02	$ 0.02	$ 0.02	$ 0.01
Diluted	$ 0.02	$ 0.02	$ 0.02	$ 0.01
Weighted average common shares
Basic	52,548,101	52,142,225	52,404,049	51,968,496
Diluted	53,484,674	53,365,025	54,286,492	52,676,707
Plasma Industry [Member]
Revenues
Total revenues	$ 11,061,712	$ 9,829,811	$ 30,436,240	$ 25,030,376
Pharmaceutical Industry [Member]
Revenues
Total revenues	1,026,270	693,353	2,345,068	2,273,232
Other Revenue [Member]
Revenues
Total revenues	$ 312,343	$ 73,264	$ 803,358	$ 112,235